How to Build a Wealthy Dynasty, Singapore Style
Welcome to Singapore Edition. Each week we bring you insights into one of Asia's most dynamic economies. If you haven't yet, please sign up here.
This week, Bernadette Toh wonders where all the rich families live, Ishika Mookerjee looks at buying property in New Zealand, and Alfred Cang investigates the long reckoning of a Mongolian murder.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 days ago
- Yahoo
Oyu Tolgoi alters mine development plan
The Oyu Tolgoi Board of Directors has sanctioned an alternative development plan for the Oyu Tolgoi copper and gold mine, as discussions persist with Entrée Resources and the Mongolian Government regarding the transfer of licences for mining in the Entrée joint venture (JV) area. This decision arrives amidst the steady progress of the mine, with production from Panel 0 and Panel 2 anticipated in 2025 and 2026, respectively, aligning with Rio Tinto's 2025 copper output forecast of 780,000–850,000 tonnes (t). The mine's exceptional ore body offers several potential development routes. Under the original plan, Panel 1, encompassing the Entrée JV area, was set to bolster production from 2027. However, development efforts in this area are now on hold until the Mongolian Government processes the licence transfer from Entrée to Oyu Tolgoi. Meanwhile, limited work will proceed in Panel 1 outside the JV zone, with resources being reallocated to advance development in Panel 2 South, which is not part of the JV. Rio Tinto Copper chief executive Katie Jackson said: 'Oyu Tolgoi continues to ramp-up as planned, with the cave performing above expectations. Our understanding of the ore body is growing as production and development progresses, further increasing our confidence and flexibility. With lateral development work only just beginning in Panel 1, this is the right time to pivot and bring forward development in Panel 2 South to maintain our options. "Transferring the licences for the Entrée joint venture area will maximise the value Oyu Tolgoi delivers for all parties, and we are continuing to work with the Government of Mongolia and Entrée Resources towards this outcome.' The production ramp-up at Oyu Tolgoi is on course to yield an average of approximately 500,000 tonnes per annum (tpa) of copper from 2028 to 2036. The plan allows for the commencement of mining operations in either Panel 1 or Panel 2 South, depending on the completion of the Entrée licence transfers. Given that lateral development in Panel 1 has only recently started, it is an opportune moment to advance the development of Panel 2 South in order to preserve flexibility. Oyu Tolgoi, the operator of the Oyu Tolgoi mine, is a JV between Rio Tinto, which holds a 66% stake, and the Mongolian Government, which owns the remaining 34%. In addition, Rio Tinto announced in November of the previous year its partnership with China's State Power Investment Corporation to test battery swap technology for electric haul trucks at the mine. This two-year initiative will involve eight haul trucks with 91t payloads, 13 batteries boasting 800 kilowatt-hours of capacity, and a robotic battery swap and charging station. The initial truck is set to arrive at Oyu Tolgoi this year, with the entire fleet and associated infrastructure set for commissioning by mid-2025. "Oyu Tolgoi alters mine development plan" was originally created and published by Mining Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Associated Press
03-06-2025
- Associated Press
Bioxytran's Groundbreaking Stroke & Alzheimer's Tech Gains Validation That Measures Oxygenation Uptake During Strokes
Mongolian Gerbil Research Unlocks Critical Insights for Ischemic Stroke and Neurodegenerative Disease Treatments BOSTON, MASSACHUSETTS, June 03, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the 'Company'), a clinical stage biotechnology company developing drugs to treat stroke and Alzheimer's disease, announced that Bioxtran's Science Advisor Prof. Avraham Mayevsky's book titled The Mongolian Gerbil Brain: Mitochondrial Function, Vasculature, and Pathophysiological States was published by a publishing house, Springer. It is available by eBook or Hardcover. The publication serves as a scientific cornerstone for Bioxytran's clinical development program of the universal oxygen carrier (UOC) in ischemic stroke and Alzheimer's disease, and is directly tied to the use of the MDX Viewer as an analytical method to detect a brain regions response to the addition of a UOC. The device has FDA approval to measure tissue oxygenation. Bioxytran is pioneering a transformative approach to treating ischemic stroke and neurodegenerative disease. The UOC is capable of replacing hyperbaric oxygen treatment (HBOT) by efficiently delivering therapeutic type of oxygen at the cellular level versus a charged version of oxygen prevalent in HBOT treatment called reactive oxygen species (ROS). This breakthrough is powered by the MDX viewer that provides real-time metabolic insights – a crucial element of Bioxytran's regulatory approach. The Mongolian gerbil brain is special in that it lacks the vasculature compensatory mechanisms that can deal with decreased blood flow in the event of a stroke. Since the blood vessels in the Mongolian gerbil brain have no coping mechanism it makes them ideal in studying stroke pathophysiology. The research compiled in this publication further validates Bioxytran's scientific and clinical approach, positioning the company on the cutting edge of advancements in brain health and neuroprotective treatments. 'This research is paving the way for substantial advances in the understanding of the pathology of stroke and other neurodegenerative diseases, said Avraham Mayevsky, Member of Bioxytran's Medical Advisory Board. 'One of the biggest challenges in in clinical trials is determining the efficacy of a drug. This gerbil brain model has great predictive value in ischemic stroke and Alzheimer's disease. The gerbil model coupled with the MDX Viewer will provide us amazing insight in the pathogenesis of stroke and neurodegenerative diseases. Over 60 years went toward the development of the book which highlights a model of how brain anomalies are detected using this device.' About Bioxytran, Inc. Bioxytran, Inc. is at the forefront of developing complex carbohydrate-based therapeutics to address critical unmet medical needs in its three core platform technologies. These include virology, cancer metastasis, and oxygen transport. In addition to ProLectin-M, Bioxytran is advancing programs for pulmonary fibrosis and stroke treatment. When utilized by paramedics at the time of diagnosis BXT-25 has the possibility of reducing what is known as the time until needle by over 90%. For more information, visit Investor Relations Michael Sheikh 509-991-0245 [email protected] Forward-Looking Statements This press release includes forward-looking statements as defined under federal law, including those related to the performance of technology described in this press release. These forward-looking statements are generally identified by the words 'believe,' 'expect,' 'anticipate,' 'estimate,' 'intend,' 'plan,' and similar expressions, although not all forward-looking statements contain these identifying words. Such statements are subject to significant risks, assumptions and uncertainties. Known material factors that could cause Bioxytran's actual results to differ materially from the results contemplated by such forward-looking statements are described in the forward-looking statements and risk factors in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and those risk factors set forth from time-to-time in other filings with the Securities and Exchange Commission. Bioxytran undertakes no obligation to correct or update any forward-looking statement, whether as a result of new information, future events, or otherwise, except to the extent required under federal securities laws.
Politico
03-06-2025
- Politico
Mongolia's prime minister resigns after losing vote of confidence
WASHINGTON — Mongolia 's prime minister resigned early Tuesday after he failed to receive enough support in a vote of confidence in parliament, Mongolian media reported. The country's embassy in Washington confirmed it. Prime Minister Oyun-Erdene Luvsannamsrai received 44 votes, well short of the 64 needed, according to news site The vote followed weeks of protests sparked by reports of lavish spending by the prime minister's son. Some called for the prime minister to step down. Before the vote, Oyun-Erdene warned that the vote could lead to instability and shake Mongolia's fledgling democracy. 'If governance becomes unstable, the economic situation deteriorates, and political parties cannot come to consensus. It could lead the public to lose faith in parliamentary rule and potentially put our democratic parliamentary system at risk of collapse,' he said. He defended his integrity but acknowledged a mistake: 'dedicating too much time to major projects while paying insufficient attention to social and internal political matters.' Oyun-Erdene had held the post for four years and survived previous calls to step down. Last year, parliament was enlarged from 76 seats to 126 following electoral reforms. It resulted in a coalition government. Landlocked between Russia and China, Mongolia has struggled to become more democratic after its party-state era. A communist state during the Cold War, it has been transforming into a democracy since the collapse of the Soviet Union. Protesters have said the country's mineral riches have benefited business interests and the wealthy, while many Mongolians still live in poverty. 'It's very difficult to build that foundation for democracy' at a time that Mongolia also must tackle economic problems, which are a major source of people's frustration, said Erin Murphy, deputy director and senior fellow of India and emerging Asian economics at the Center for Strategic and International Studies. 'We still have to see what happens next and how the new government plans to tackle these issues,' she said. While democracy is yet to thrive in Mongolia, 'it is taking root,' Murphy said.
